迈威生物：董事长提议2500万元至5000万元回购股份

Core Viewpoint - The company plans to repurchase a portion of its issued A-shares through a centralized bidding trading method on the Shanghai Stock Exchange, with a total repurchase fund of no less than RMB 25 million and no more than RMB 50 million, at a price not exceeding RMB 35 per share [1] Group 1 - The repurchased shares will be used for employee stock ownership plans or equity incentives at an appropriate time in the future [1] - If the shares are not fully utilized within three years after the announcement of the repurchase results, they will be canceled [1] - The source of the repurchase funds will be from the company's own funds and/or special loans for stock repurchase [1] Group 2 - The proposal is valid for 12 months from the date of approval by the board of directors [1]